242 related articles for article (PubMed ID: 1620343)
1. Content of the neurotoxins cycasin (methylazoxymethanol beta-D-glucoside) and BMAA (beta-N-methylamino-L-alanine) in cycad flour prepared by Guam Chamorros.
Kisby GE; Ellison M; Spencer PS
Neurology; 1992 Jul; 42(7):1336-40. PubMed ID: 1620343
[TBL] [Abstract][Full Text] [Related]
2. 2-Amino-3-(methylamino)-propanoic acid (BMAA) in cycad flour: an unlikely cause of amyotrophic lateral sclerosis and parkinsonism-dementia of Guam.
Duncan MW; Steele JC; Kopin IJ; Markey SP
Neurology; 1990 May; 40(5):767-72. PubMed ID: 2330104
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam.
Murch SJ; Cox PA; Banack SA; Steele JC; Sacks OW
Acta Neurol Scand; 2004 Oct; 110(4):267-9. PubMed ID: 15355492
[TBL] [Abstract][Full Text] [Related]
4. Previous studies underestimate BMAA concentrations in cycad flour.
Cheng R; Banack SA
Amyotroph Lateral Scler; 2009; 10 Suppl 2():41-3. PubMed ID: 19929730
[TBL] [Abstract][Full Text] [Related]
5. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam.
Cox PA; Banack SA; Murch SJ
Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13380-3. PubMed ID: 14612559
[TBL] [Abstract][Full Text] [Related]
6. Creating a Simian Model of Guam ALS/PDC Which Reflects Chamorro Lifetime BMAA Exposures.
Banack SA; Cox PA
Neurotox Res; 2018 Jan; 33(1):24-32. PubMed ID: 28478528
[TBL] [Abstract][Full Text] [Related]
7. Parkinsonism and motor neuron disorders: Lessons from Western Pacific ALS/PDC.
Spencer PS
J Neurol Sci; 2022 Feb; 433():120021. PubMed ID: 34635325
[TBL] [Abstract][Full Text] [Related]
8. Cycad β-N-methylamino-L-alanine (BMAA), methylazoxymethanol, genotoxicity, and neurodegeneration.
Spencer PS; Palmer VS; Kisby GE
Toxicon; 2018 Dec; 155():49-50. PubMed ID: 30316979
[TBL] [Abstract][Full Text] [Related]
9. Biomagnification of cycad neurotoxins in flying foxes: implications for ALS-PDC in Guam.
Banack SA; Cox PA
Neurology; 2003 Aug; 61(3):387-9. PubMed ID: 12913204
[TBL] [Abstract][Full Text] [Related]
10. A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.
Chernoff N; Hill DJ; Diggs DL; Faison BD; Francis BM; Lang JR; Larue MM; Le TT; Loftin KA; Lugo JN; Schmid JE; Winnik WM
J Toxicol Environ Health B Crit Rev; 2017; 20(4):1-47. PubMed ID: 28598725
[TBL] [Abstract][Full Text] [Related]
11. Return of the cycad hypothesis - does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health?
Ince PG; Codd GA
Neuropathol Appl Neurobiol; 2005 Aug; 31(4):345-53. PubMed ID: 16008818
[TBL] [Abstract][Full Text] [Related]
12. Animal models of BMAA neurotoxicity: a critical review.
Karamyan VT; Speth RC
Life Sci; 2008 Jan; 82(5-6):233-46. PubMed ID: 18191417
[TBL] [Abstract][Full Text] [Related]
13. Quantification of the putative neurotoxin 2-amino-3-(methylamino)propanoic acid (BMAA) in cycadales: analysis of the seeds of some members of the family Cycadaceae.
Duncan MW; Kopin IJ; Crowley JS; Jones SM; Markey SP
J Anal Toxicol; 1989; 13(4):suppl A-G. PubMed ID: 2490746
[TBL] [Abstract][Full Text] [Related]
14. The Guam cycad toxin methylazoxymethanol damages neuronal DNA and modulates tau mRNA expression and excitotoxicity.
Esclaire F; Kisby G; Spencer P; Milne J; Lesort M; Hugon J
Exp Neurol; 1999 Jan; 155(1):11-21. PubMed ID: 9918700
[TBL] [Abstract][Full Text] [Related]
15. A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam.
Murch SJ; Cox PA; Banack SA
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12228-31. PubMed ID: 15295100
[TBL] [Abstract][Full Text] [Related]
16. The cycad neurotoxic amino acid, beta-N-methylamino-L-alanine (BMAA), elevates intracellular calcium levels in dissociated rat brain cells.
Brownson DM; Mabry TJ; Leslie SW
J Ethnopharmacol; 2002 Oct; 82(2-3):159-67. PubMed ID: 12241991
[TBL] [Abstract][Full Text] [Related]
17. Western Pacific ALS-PDC: Evidence implicating cycad genotoxins.
Spencer PS; Palmer VS; Kisby GE
J Neurol Sci; 2020 Dec; 419():117185. PubMed ID: 33190068
[TBL] [Abstract][Full Text] [Related]
18. Overview of the potent cyanobacterial neurotoxin β-methylamino-L-alanine (BMAA) and its analytical determination.
Porojan C; Mitrovic SM; Yeo DC; Furey A
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2016 Oct; 33(10):1570-1586. PubMed ID: 27652898
[TBL] [Abstract][Full Text] [Related]
19. Cycad neurotoxins, consumption of flying foxes, and ALS-PDC disease in Guam.
Cox PA; Sacks OW
Neurology; 2002 Mar; 58(6):956-9. PubMed ID: 11914415
[TBL] [Abstract][Full Text] [Related]
20. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases.
Bradley WG; Mash DC
Amyotroph Lateral Scler; 2009; 10 Suppl 2():7-20. PubMed ID: 19929726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
